Literature DB >> 6187679

The distribution of DR5, MT2, and MB3 specificities on human Ia subsets.

N Tanigaki, R Tosi, K Sagawa, J Minowada, G B Ferrara.   

Abstract

Human Ia molecules were isolated from cells of LG-38, an HLA-homozygous lymphoid cell line of DR5 specificity. Three Ia subsets could be distinguished and separated by using specific alloantisera and a monoclonal antibody with polymorphic reactivity. These subsets carried the specificities DR5 and MT2, MT2 alone and MB3 alone. The structure of the three molecular species was analyzed by microfingerprinting. The subset carrying only MT2 was similar, in both the component alpha and beta chains, to the major subset carrying DR5 and MT2, whereas the subset carrying MB3 was distinct in both chains from the other two subsets. These data are compatible with our previous findings obtained for the products of two Ia loci closely linked to the DR locus and provisionally called DC and BR; they also support the conclusion that the subset carrying only MT2 is an allelic product of the BR locus, whereas the MB3 subset is an allelic product of the DC locus. MT2 appears to be a shared specificity of DR and BR loci products.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187679     DOI: 10.1007/bf00372456

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  26 in total

1.  Cross-reactivity between the first and second segregant series of the HLA system.

Authors:  M Scalamogna; F Mercuriali; C Pizzi; G Sirchia
Journal:  Tissue Antigens       Date:  1976-02

2.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  Identification of an HLA-DR-associated system of B-cell alloantigens.

Authors:  R J Duquesnoy; M Marrari; K Annen
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The complexity of the HL-A gene product. II. Possible evidence for a "public" determinant common to the first and second HL-A series.

Authors:  L Legrand; J Dausset
Journal:  Transplantation       Date:  1975-02       Impact factor: 4.939

6.  Murine Ia and human DR antigens: homology of amino-terminal sequences.

Authors:  J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; J A Frelinger; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  Structural polymorphism of human DR antigens.

Authors:  J Silver; S Ferrone
Journal:  Nature       Date:  1979-05-31       Impact factor: 49.962

8.  Structural studies on the murine Ia alloantigens. IV. NH2-terminal sequence analysis of allelic products of the I-A and I-E/C subregions.

Authors:  R G Cook; M H Siegelman; J D Capra; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

10.  Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivity.

Authors:  D B Murphy; D C Shrefler
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  19 in total

1.  Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.

Authors:  M L Bosch; A Termijtelen; R Gerrets; G M Schreuder; R E Bontrop; M J Giphart
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Serological discrimination of DR4 haplotypes by radioimmunoassay.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Analysis of the DR beta chains from two DRw6 cell lines (WT46 and WT52): recombination in vivo may have generated new haplotypes.

Authors:  P J Knudsen; J McLean; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype.

Authors:  L K Myers; E J Ball; G Nuñez; P Stastny
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5).

Authors:  P Loiseau; P Lehn; F Dautry; V Lepage; J Colombani; D Cohen; J Dausset; L Degos
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Southern blot and microfingerprinting analysis of two DR7 haplotypes.

Authors:  G Angelini; N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

7.  Subset analysis of human class II molecules controlled by the DR2/Dw2 haplotype: two separate DR subsets carry the DR2 specificity.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Serological recognition of HLA-DR allodeterminant corresponding to DNA sequence involved in gene conversion.

Authors:  C C Berte; N Tanigaki; R Tosi; J Gorski; B Mach
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes.

Authors:  R Tosi; M Vela; D Adorno; A Longo; F Papola; D Maccarone; D Centis; N Tanigaki; M P Raponi; A Candela
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

10.  Immunochemistry of the HLA class II molecules isolated from a mouse cell transfected with DQ alpha and beta genes from a DR4 haplotype.

Authors:  N Tanigaki; R Tosi; J L Strominger; J Cooper
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.